Edwards Lifesciences (EW) Net Margin (2009 - 2026)
Edwards Lifesciences (EW) posted Net Margin of 13.87% for Q2 2026, down 39.96% on a QoQ basis from 23.09% in Q1 2026, and down 777.0% year-over-year from 2.05% in Q2 2025.
Powered by 
Analysis
Edwards Lifesciences (EW) Net Margin (2009 - 2026) Analysis & Trends
Edwards Lifesciences has reported Net Margin for 18 years, with the latest figure at 13.87% in Q2 2026.
- On a quarterly basis, Net Margin fell 777.0% year-over-year to 13.87% in Q2 2026; TTM through Jun 2026 was 15.41%, a 5744.0% decrease from a year earlier, with the FY2025 full-year figure at 17.62%, down 5903.0% from the prior year.
- Net Margin was 13.87% for Q2 2026 at Edwards Lifesciences, down from 23.09% in the prior quarter.
- The five-year high for Net Margin was 226.62% in Q3 2024, with the low at 5.81% in Q4 2025.
- Average Net Margin over 5 years is 39.11%, with a median of 26.52% recorded in 2024.
- The sharpest annual moves came in 2024 and 2025: Net Margin surged 19577 bps in 2024, then slumped 20793 bps in 2025.
- Over 5 years, Net Margin stood at 92.67% in 2022, then sank by 68 bps to 29.19% in 2023, then fell by 5 bps to 27.73% in 2024, then plunged by 79 bps to 5.81% in 2025, then soared by 139 bps to 13.87% in 2026.
- The last three Net Margin figures came in at 13.87% (Q2 2026), 23.09% (Q1 2026), and 5.81% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 7.37% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 28.46% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 15.17% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 19.37% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 16.67% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 13.87% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 19.04% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 13.47% |
| 10 | Zimmer Biomet Holdings | 18.20 Bn | 17.79 Bn | 1.54 Bn | 9.17% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.87% |
| Mar 31, 2026 | 23.09% |
| Dec 31, 2025 | 5.81% |
| Sep 30, 2025 | 18.69% |
| Jun 30, 2025 | 21.64% |
| Mar 31, 2025 | 25.23% |
| Dec 31, 2024 | 27.73% |
| Sep 30, 2024 | 226.62% |
| Jun 30, 2024 | 26.65% |
| Mar 31, 2024 | 26.39% |
| Dec 31, 2023 | 29.19% |
| Sep 30, 2023 | 30.86% |
| Jun 30, 2023 | 24.11% |
| Mar 31, 2023 | 27.88% |
| Dec 31, 2022 | 92.67% |
| Sep 30, 2022 | 26.04% |
| Jun 30, 2022 | 29.58% |
| Mar 31, 2022 | 27.86% |
| Dec 31, 2021 | 25.22% |
| Sep 30, 2021 | 25.96% |